{"id":46799,"date":"2022-08-01T18:01:40","date_gmt":"2022-08-01T16:01:40","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\/"},"modified":"2022-08-01T18:01:40","modified_gmt":"2022-08-01T16:01:40","slug":"thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\/","title":{"rendered":"Thomas Park Investments Reports Strong First Half with $75M in MOB Acquisitions"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>Company Expands into Southeast with Raleigh, North Carolina Purchase<\/i>\n<\/p>\n<p>ANNAPOLIS, Md.&#8211;(BUSINESS WIRE)&#8211;Thomas Park Investments closed the first half of 2022 with $75 million in medical office building (MOB) acquisitions, halfway toward the company\u2019s goal of $150 million in acquisitions this year. The acquisitions include a purchase in Raleigh, North Carolina, signaling the company\u2019s expansion into the southeast.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220801005592\/en\/1530580\/4\/Thomas_Park_Investments_logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220801005592\/en\/1530580\/21\/Thomas_Park_Investments_logo.jpg\"><\/a><\/p>\n<p>\n\u201cThese acquisitions add some of the most trusted names in health care to our roster of tenants, including Duke Health, UNC Physicians Network, Penn Medicine, University of Maryland Medical System, South Shore Health, and St. Luke\u2019s,\u201d says EJ Rumpke, Thomas Park\u2019s Chief Executive Officer. \u201cWe\u2019re pleased with the increased diversity of tenants and health systems these recent acquisitions bring to our portfolio.\u201d\n<\/p>\n<p>\nFirst half acquisitions include:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fthomas-park.com%2Fproperties%2F8300-health-park%2F&amp;esheet=52797773&amp;newsitemid=20220801005592&amp;lan=en-US&amp;anchor=8300+Health+Park&amp;index=1&amp;md5=a4f3910a4c4862724421a1a301328f32\" rel=\"nofollow noopener\" shape=\"rect\"><b>8300 Health Park<\/b><\/a><b> in Raleigh, North Carolina.<\/b> This 178,000-square foot MOB was acquired off-market and is anchored by Carolina Family Practice &amp; Sports Medicine (Duke Health), Boylan Healthcare (UNC Physicians Network), Healthtrax, and Raleigh Endoscopy.\n<\/li>\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fthomas-park.com%2Fproperties%2F5000-dearborn-circle%2F&amp;esheet=52797773&amp;newsitemid=20220801005592&amp;lan=en-US&amp;anchor=5000+Dearborn+Circle&amp;index=2&amp;md5=99cd567f4b9dbce295ed326675c68824\" rel=\"nofollow noopener\" shape=\"rect\"><b>5000 Dearborn Circle<\/b><\/a><b> in Mt. Laurel, New Jersey<\/b>. This 56,000-square-foot MOB is anchored by Penn Medicine and was acquired in an off-market transaction. This core plus acquisition expands Thomas Park\u2019s presence in the greater Philadelphia market.\n<\/li>\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fthomas-park.com%2Fproperties%2F8322-bellona-ave%2F&amp;esheet=52797773&amp;newsitemid=20220801005592&amp;lan=en-US&amp;anchor=8322+Bellona+Avenue&amp;index=3&amp;md5=954dfb51e039ebccc4e61509db822e2b\" rel=\"nofollow noopener\" shape=\"rect\"><b>8322 Bellona Avenue<\/b><\/a><b> in Baltimore, Maryland.<\/b> This 56,000-square-foot MOB was acquired off market in a partial sale-leaseback. The building is anchored by Towson Orthopaedic Associates, part of the University of Maryland St. Joseph Medical Center.\n<\/li>\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fthomas-park.com%2Fproperties%2F223-chief-justice-cushing-highway%2F&amp;esheet=52797773&amp;newsitemid=20220801005592&amp;lan=en-US&amp;anchor=223+Chief+Justice+Cushing+Parkway&amp;index=4&amp;md5=072fe30000c542e9e3f9c28802f5fef6\" rel=\"nofollow noopener\" shape=\"rect\"><b>223 Chief Justice Cushing Parkway<\/b><\/a><b> in Cohasset, Massachusetts.<\/b> The 35,000-square-foot core plus purchase was acquired off market and is in a highly desirable and affluent submarket of Boston. It\u2019s anchored by HealthCare South and South Shore Children\u2019s Dentistry.\n<\/li>\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fthomas-park.com%2Fproperties%2F5325-northgate-drive%2F&amp;esheet=52797773&amp;newsitemid=20220801005592&amp;lan=en-US&amp;anchor=5325+Northgate+Drive&amp;index=5&amp;md5=48830003b75aa91f8b0e1d431d806703\" rel=\"nofollow noopener\" shape=\"rect\"><b>5325 Northgate Drive<\/b><\/a><b> in Bethlehem, Pennsylvania.<\/b> This 53,000-square-foot value-add purchase involves a partial sale-leaseback. Anchor tenants include Wills Eye Physicians (Mid Atlantic Retina), Radiology &amp; MRI of Bethlehem, and Bethlehem Endoscopy.\n<\/li>\n<\/ul>\n<p>\n\u201cOur significant growth says a lot about the caliber of our team,\u201d says Thomas Park\u2019s Chief Operating Officer Gene Parker. \u201cAnd our growth has fueled a hiring expansion, raising our headcount by 125% since the beginning of the year.\u201d\n<\/p>\n<p>\nAccording to Alex Kopicki, Thomas Park\u2019s Chief Investment Officer, rising interest rates will not slow the company\u2019s momentum. \u201cWe have a knack for finding good real estate that can weather the short-term volatility of the debt markets, as we predominantly have a long-term outlook on the health care real estate sector,\u201d he said.\n<\/p>\n<p>\n<b>About Thomas Park Investments<\/b>\n<\/p>\n<p>\nThomas Park Investments is a leading private equity real estate firm specializing in health care real estate. Founded in 2019, Thomas Park\u2019s leadership has more than sixty years of commercial real estate experience and manages more than 825,000 square feet of commercial space. The Annapolis, Maryland based firm is on pace to have $1 billion of assets under management by 2025. For more information, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.thomas-park.com%2F&amp;esheet=52797773&amp;newsitemid=20220801005592&amp;lan=en-US&amp;anchor=thomas-park.com&amp;index=6&amp;md5=2dab36e2ed940b94cbf1137abc6dc348\" rel=\"nofollow noopener\" shape=\"rect\">thomas-park.com<\/a>.\n<\/p>\n<p>\n<b>Photos available upon request.<\/b>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>For more information contact:<\/b><br \/>Kristy Myers, Cardinal Thread<br \/>\n<br \/>240-434-1274<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#97;&#x69;&#x6c;&#116;&#111;&#x3a;&#x6b;&#114;&#105;&#x73;&#x74;&#121;&#64;&#x63;&#x61;&#114;&#100;&#x69;&#x6e;&#97;&#108;&#x74;&#x68;&#114;&#101;&#x61;&#x64;&#46;&#99;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">k&#114;&#105;&#115;&#x74;&#x79;&#x40;ca&#114;&#100;&#x69;&#x6e;&#x61;&#x6c;th&#114;&#101;&#x61;&#x64;&#x2e;&#x63;o&#109;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Company Expands into Southeast with Raleigh, North Carolina Purchase ANNAPOLIS, Md.&#8211;(BUSINESS WIRE)&#8211;Thomas Park Investments closed the first half of 2022 with $75 million in medical office building (MOB) acquisitions, halfway toward the company\u2019s goal of $150 million in acquisitions this year. The acquisitions include a purchase in Raleigh, North Carolina, signaling the company\u2019s expansion into &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46799","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Thomas Park Investments Reports Strong First Half with $75M in MOB Acquisitions - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Thomas Park Investments Reports Strong First Half with $75M in MOB Acquisitions - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Company Expands into Southeast with Raleigh, North Carolina Purchase ANNAPOLIS, Md.&#8211;(BUSINESS WIRE)&#8211;Thomas Park Investments closed the first half of 2022 with $75 million in medical office building (MOB) acquisitions, halfway toward the company\u2019s goal of $150 million in acquisitions this year. The acquisitions include a purchase in Raleigh, North Carolina, signaling the company\u2019s expansion into ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-01T16:01:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220801005592\/en\/1530580\/21\/Thomas_Park_Investments_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Thomas Park Investments Reports Strong First Half with $75M in MOB Acquisitions\",\"datePublished\":\"2022-08-01T16:01:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\\\/\"},\"wordCount\":493,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220801005592\\\/en\\\/1530580\\\/21\\\/Thomas_Park_Investments_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\\\/\",\"name\":\"Thomas Park Investments Reports Strong First Half with $75M in MOB Acquisitions - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220801005592\\\/en\\\/1530580\\\/21\\\/Thomas_Park_Investments_logo.jpg\",\"datePublished\":\"2022-08-01T16:01:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220801005592\\\/en\\\/1530580\\\/21\\\/Thomas_Park_Investments_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220801005592\\\/en\\\/1530580\\\/21\\\/Thomas_Park_Investments_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Thomas Park Investments Reports Strong First Half with $75M in MOB Acquisitions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Thomas Park Investments Reports Strong First Half with $75M in MOB Acquisitions - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\/","og_locale":"en_US","og_type":"article","og_title":"Thomas Park Investments Reports Strong First Half with $75M in MOB Acquisitions - Pharma Trend","og_description":"Company Expands into Southeast with Raleigh, North Carolina Purchase ANNAPOLIS, Md.&#8211;(BUSINESS WIRE)&#8211;Thomas Park Investments closed the first half of 2022 with $75 million in medical office building (MOB) acquisitions, halfway toward the company\u2019s goal of $150 million in acquisitions this year. The acquisitions include a purchase in Raleigh, North Carolina, signaling the company\u2019s expansion into ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-01T16:01:40+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220801005592\/en\/1530580\/21\/Thomas_Park_Investments_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Thomas Park Investments Reports Strong First Half with $75M in MOB Acquisitions","datePublished":"2022-08-01T16:01:40+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\/"},"wordCount":493,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220801005592\/en\/1530580\/21\/Thomas_Park_Investments_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\/","url":"https:\/\/pharma-trend.com\/en\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\/","name":"Thomas Park Investments Reports Strong First Half with $75M in MOB Acquisitions - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220801005592\/en\/1530580\/21\/Thomas_Park_Investments_logo.jpg","datePublished":"2022-08-01T16:01:40+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220801005592\/en\/1530580\/21\/Thomas_Park_Investments_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220801005592\/en\/1530580\/21\/Thomas_Park_Investments_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/thomas-park-investments-reports-strong-first-half-with-75m-in-mob-acquisitions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Thomas Park Investments Reports Strong First Half with $75M in MOB Acquisitions"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46799","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46799"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46799\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46799"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46799"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46799"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}